{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:53:22Z","timestamp":1791240802860,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":277,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Traumatic brain injury (TBI) often results in serious neuronal tissue damage that can lead to progressive neurological impairment. NeuroD1, a transcription factor involved in neuronal differentiation, may be able to facilitate recovery post-TBI through the promotion of both neuroprotection and astrocyte-to-neuron reprogramming. The efficacy and optimal parameters for NeuroD1-based treatment, however, remain uncertain. This study investigated the effects of AAV-mediated NeuroD1 delivery in TBI mouse models, focusing on cellular reprogramming at low dosages. Dose response experiments revealed that lower viral doses provided the greatest transduction specificity. Notably, lower viral titers resulted in greater astrocyte-specific transduction whereas higher titers increased transduction in off-targets (neurons), potentially due to toxicity and\/or leakage. Using these low dosages, our findings indicate that NeuroD1 treatment did not produce statistically significant structural restoration, nor did it greatly alter neuroinflammation measures; however, it did allow for functional improvement in beam walk performance, suggesting enhanced neurological recovery. Prospective studies should refine experimental conditions, incorporate a broader range of behavioral assessments, and explore combination therapies to enhance both functional and structural recovery. NeuroD1-based interventions remain a promising avenue for promoting functional improvement following TBI, although further research is required to drive these findings to clinical applications.<\/jats:p>","DOI":"10.1007\/s12035-026-06244-6","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:10:44Z","timestamp":1791238244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low Dose NeuroD1 Delivery in Mouse TBI Models"],"prefix":"10.1007","volume":"63","author":[{"given":"Isaac H.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansharah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"With","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Roushdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilmareth","family":"Natera-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Erlanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"12","key":"6244_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","volume":"16","author":"AIR Maas","year":"2017","unstructured":"Maas AIR et al (2017) Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol 16(12):987\u20131048. https:\/\/doi.org\/10.1016\/S1474-4422(17)30371-X","journal-title":"Lancet Neurol"},{"issue":"9","key":"6244_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/nn.2385","volume":"12","author":"Z Gao","year":"2009","unstructured":"Gao Z et al (2009) Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci 12(9):1090\u20131092. https:\/\/doi.org\/10.1038\/nn.2385","journal-title":"Nat Neurosci"},{"issue":"3","key":"6244_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1523\/JNEUROSCI.4832-07.2008","volume":"28","author":"H Liu","year":"2008","unstructured":"Liu H et al (2008) NeuroD1 regulates expression of thyroid hormone receptor 2 and cone opsins in the developing mouse retina. J Neurosci Off J Soc Neurosci 28(3):749\u2013756. https:\/\/doi.org\/10.1523\/JNEUROSCI.4832-07.2008","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"1","key":"6244_CR4","doi-asserted-by":"publisher","first-page":"17980","DOI":"10.1038\/s41598-022-22802-z","volume":"12","author":"K Matsuda-Ito","year":"2022","unstructured":"Matsuda-Ito K et al (2022) Expression level of the reprogramming factor NeuroD1 is critical for neuronal conversion efficiency from different cell types. Sci Rep 12(1):17980. https:\/\/doi.org\/10.1038\/s41598-022-22802-z","journal-title":"Sci Rep"},{"issue":"1","key":"6244_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ymthe.2019.09.003","volume":"28","author":"Y-C Chen","year":"2020","unstructured":"Chen Y-C et al (2020) A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion. Mol Ther 28(1):217\u2013234. https:\/\/doi.org\/10.1016\/j.ymthe.2019.09.003","journal-title":"Mol Ther"},{"issue":"5","key":"6244_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/dneu.22882","volume":"82","author":"NX Ma","year":"2022","unstructured":"Ma NX et al (2022) Transcriptomic analyses of NeuroD1-mediated astrocyte-to-neuron conversion. Dev Neurobiol 82(5):375\u2013391. https:\/\/doi.org\/10.1002\/dneu.22882","journal-title":"Dev Neurobiol"},{"key":"6244_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.conb.2016.11.011","volume":"42","author":"F Guillemot","year":"2017","unstructured":"Guillemot F, Hassan BA (2017) Beyond proneural: emerging functions and regulations of proneural proteins. Curr Opin Neurobiol 42:93\u2013101. https:\/\/doi.org\/10.1016\/j.conb.2016.11.011","journal-title":"Curr Opin Neurobiol"},{"key":"6244_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.conb.2017.10.025","volume":"47","author":"S Falk","year":"2017","unstructured":"Falk S, G\u00f6tz M (2017) Glial control of neurogenesis. Curr Opin Neurobiol 47:188\u2013195. https:\/\/doi.org\/10.1016\/j.conb.2017.10.025","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"6244_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B","volume":"26","author":"A Nagy","year":"2000","unstructured":"Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis (New York, N.Y.: 2000) 26(2):99\u2013109","journal-title":"Genesis (New York, N.Y.: 2000)"},{"issue":"1","key":"6244_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/2211-5463.13029","volume":"11","author":"Y Dou","year":"2020","unstructured":"Dou Y, Dou Y et al (2020) The CAG promoter maintains high\u2010level transgene expression in HEK293 cells. FEBS Open Bio 11(1):95\u2013104. https:\/\/doi.org\/10.1002\/2211-5463.13029","journal-title":"FEBS Open Bio"},{"issue":"2","key":"6244_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.stem.2013.12.001","volume":"14","author":"Z Guo","year":"2014","unstructured":"Guo Z et al (2014) In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer\u2019s disease model. Cell Stem Cell 14(2):188\u2013202. https:\/\/doi.org\/10.1016\/j.stem.2013.12.001","journal-title":"Cell Stem Cell"},{"key":"6244_CR12","doi-asserted-by":"publisher","unstructured":"Bankhead P et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7(1):16878. www.nature.com, https:\/\/doi.org\/10.1038\/s41598-017-17204-5","DOI":"10.1038\/s41598-017-17204-5"},{"key":"6244_CR13","doi-asserted-by":"publisher","unstructured":"Chen G et al (2020) Comment on \u201cRapid and efficient in vivo astrocyte-to-neuron conversion with regional identity and connectivity?\u201d bioRxiv\u00a0 3:2020.09.02.279273. bioRxiv.\u00a0https:\/\/doi.org\/10.1101\/2020.09.02.279273","DOI":"10.1101\/2020.09.02.279273"},{"key":"6244_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7\u201335. https:\/\/doi.org\/10.1007\/s00401-009-0619-8","journal-title":"Acta Neuropathol"},{"key":"6244_CR15","doi-asserted-by":"publisher","unstructured":"Clark IH et al (2025) Astrocyte to neuron reprogramming with NeuroD1 for repair in canine stroke. Front Stroke. https:\/\/doi.org\/10.3389\/fstro.2025.1602076","DOI":"10.3389\/fstro.2025.1602076"},{"key":"6244_CR16","doi-asserted-by":"publisher","unstructured":"Xu L et al (2022) Enhancing NeuroD1 expression to convert lineage-traced astrocytes into neurons. bioRxiv, 2022.06.21.496971. bioRxiv.\u00a0https:\/\/doi.org\/10.1101\/2022.06.21.496971","DOI":"10.1101\/2022.06.21.496971"},{"key":"6244_CR17","doi-asserted-by":"publisher","unstructured":"Kumar A et al (2012) Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2012.06.008","DOI":"10.1016\/j.bbi.2012.06.008"},{"key":"6244_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02949-w","volume":"20","author":"P Chen","year":"2023","unstructured":"Chen P et al (2023) NeuroD1 administration ameliorated neuroinflammation and boosted neurogenesis in a mouse model of subarachnoid hemorrhage. J Neuroinflammation 20:261. https:\/\/doi.org\/10.1186\/s12974-023-02949-w","journal-title":"J Neuroinflammation"},{"issue":"11","key":"6244_CR19","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1073\/pnas.0603243104","volume":"104","author":"R Mi","year":"2007","unstructured":"Mi R et al (2007) Pleiotrophin is a neurotrophic factor for spinal motor neurons. Proc Natl Acad Sci U S A 104(11):4664\u20134669. https:\/\/doi.org\/10.1073\/pnas.0603243104","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06244-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:10:44Z","timestamp":1791238244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06244-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6244"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06244-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures on live animals were approved by the University of Minnesota\u2019s Institutional Animal Care and Use Committee under protocol 2301\u201340677A.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"947"}}